What is Armonair Digihaler and how does it work?
ArmonAir Digihaler is a prescription inhaled corticosteroid (ICS) medicine for the long-term treatment of asthma in people aged 12 years and older.
- ICS medicines such as fluticasone propionate help to decrease inflammation in the lungs. Inflammation in the lungs can lead to breathing problems.
- ArmonAir Digihaler is not used to relieve sudden breathing problems.
- It is not known if
ArmonAir Digihaler is safe and effective in children younger than 12 years of age.
ArmonAir Digihaler contains a built-in electronic module that records and stores information about inhaler events.
ArmonAir Digihaler may be used with, and transmits information to, an App through Bluetooth wireless technology.
ArmonAir Digihaler does not need to be connected to the app in order for you to take your medicine. The electronic module does not control or interfere with delivery of the medicine through the inhaler.
Do not use
- to relieve sudden breathing problems.
if you have a severe allergy to milk proteins or any of the ingredients in
What are the side effects of Armonair Digihaler?
ArmonAir Digihaler can cause serious side effects, including:
- Fungal infection in your mouth and throat (thrush). Rinse your mouth with water without swallowing after using
ArmonAir Digihaler to help reduce your chance of getting thrush.
- Weakened immune system and increased chance of getting infections (immunosuppression).
- Reduced adrenal function (adrenal insufficiency). Adrenal insufficiency is a condition where the adrenal glands do not make enough steroid hormones. This can happen when you stop taking oral corticosteroid medicines (such as prednisone) and start taking a medicine containing an inhaled steroid (such as
ArmonAir Digihaler). When your body is under stress such as from fever, trauma (such as a car accident), infection, or surgery, adrenal insufficiency can get worse and may cause death.
Symptoms of adrenal insufficiency include:
- feeling tired
- lack of energy
- nausea and vomiting
- low blood pressure
- Serious allergic reactions. Call your healthcare provider or get emergency medical help if you get any of the following signs or symptoms of a serious allergic reaction:
- swelling of your face, mouth, and tongue
- breathing problems
- Bone thinning or weakness (osteoporosis).
- Slowed growth in children. A childâ€™s growth should be checked often.
- Eye problems including glaucoma and cataracts. You should have regular eye exams while using
- Increased wheezing (bronchospasm). Increased wheezing can happen right away after using
ArmonAir Digihaler. If this occurs, stop using ArmonAir Digihaler and call your healthcare provider. Always have a rescue inhaler with you to treat sudden wheezing.
Common side effects of
ArmonAir Digihaler include:
These are not all the possible side effects with
ArmonAir Digihaler. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the dosage for Armonair Digihaler?
- For detailed instructions on how to set up the App go to www.ARMONAIRDIGIHALER.com or call Teva at 1-888-603-0788.
- Connection to the App, having your Bluetooth turned on, or being near your smartphone is not required for your
ArmonAir Digihaler to work and for you to get your medicine.
- The electronic module does not control or interfere with delivery of the medicine through the inhaler.
ArmonAir Digihaler is for oral inhalation use only.
- Rinse your mouth with water without swallowing after each dose of
- Children should use ArmonAir Digihaler with an adultâ€™s help, as instructed by the childâ€™s healthcare provider.
- ArmonAir Digihaler comes in 3 different strengths. Your healthcare provider prescribed the strength that is right for you.
ArmonAir Digihaler exactly as your healthcare provider tells you to use it. Do not use
ArmonAir Digihaler more often than prescribed.
- Use ArmonAir
Digihaler 2 times a day (about 12 hours apart) at the same time every day.
ArmonAir Digihaler does not need priming. Do not use a spacer or volume holding chamber with
- Do not open the cap on your ArmonAir
Digihaler inhaler until you are ready for your dose because this will waste your medicine or may damage your inhaler.
- It may take 1 to 2 weeks or longer after you start
ArmonAir Digihaler for your asthma symptoms to get better. You must use
ArmonAir Digihaler regularly.
- Do not stop using ArmonAir
Digihaler, even if you are feeling better, unless your healthcare provider tells you to.
- If you miss a dose of
ArmonAir Digihaler, just skip that dose. Take your next dose at your usual time. Do not take 2 doses at 1 time.
ArmonAir Digihaler does not relieve sudden symptoms. Always have a rescue inhaler with you to treat sudden symptoms. If you do not have a rescue inhaler, call your healthcare provider to have one prescribed for you.
- Call your healthcare provider or get medical care right away if:
- your breathing problems get worse.
- you need to use your rescue inhaler more often than usual.
- your rescue inhaler does not work as well to relieve your symptoms.
- you need to use 4 or more inhalations of your rescue inhaler in 24 hours for 2 or more days in a row.
- you use 1 whole canister of your rescue inhaler in 8 weeks.
- your peak flow meter results decrease. Your healthcare provider will tell you the numbers that are right for you.
What drugs interact with Armonair Digihaler?
Inhibitors Of Cytochrome P450 3A4
Fluticasone propionate is a substrate of CYP3A4. The use of strong CYP3A4 inhibitors (e.g., ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, ketoconazole, telithromycin) with ArmonAir Digihaler is not recommended because increased systemic corticosteroid adverse effects may occur.
A drug interaction trial with fluticasone propionate aqueous nasal spray in
healthy subjects has shown that ritonavir (a strong CYP3A4 inhibitor) can
significantly increase plasma fluticasone propionate exposure, resulting in
significantly reduced serum cortisol concentrations. During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate and ritonavir, resulting in systemic corticosteroid effects including Cushing’s syndrome and adrenal suppression.
Coadministration of orally inhaled fluticasone propionate (1,000 mcg) and ketoconazole (200 mg once daily) resulted in a 1.9-fold increase in plasma fluticasone propionate exposure and a 45% decrease in plasma cortisol area under the curve (AUC), but had no effect on urinary excretion of cortisol.
Is Armonair Digihaler safe to use while pregnant or breastfeeding?
There are no randomized clinical studies of ArmonAir Digihaler in pregnant women.
There are no available data on the presence of fluticasone propionate in human milk, the effects on the breastfed child, or the effects on milk production. Other corticosteroids have been detected in human milk. However, fluticasone propionate concentrations in plasma after inhaled therapeutic doses are low and therefore concentrations in human breast milk are likely to be correspondingly low. The developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for ArmonAir Digihaler and any potential adverse effects on the breastfed child from ArmonAir Digihaler or from the underlying maternal condition.
Medically Reviewed on 10/2/2020
Sections courtesy of FDA prescribing information
- New blood cancer treatment works by selectively interfering with cancer cell signalling - October 22, 2020
- ClickHole Started as a Meat Joke. Can It Avoid Being Offal? - October 22, 2020
- New Canadian Bio-Economy Report Indicates Green Potential of Emerging Talent Markets - October 22, 2020
- खोजने वाले इतिहासकार” पर अन्तर्राष्ट्रीय वेबीनार 24 अक्टूबर को - October 22, 2020
- PreludeSys India Walk In 23rd Oct 2020 for Bsc BDS Bpharma Freshers and Experienced - October 22, 2020
- New Study 31/A5349 on the treatment of drug-susceptible TB - October 22, 2020
- What Is Breast Biopsy With Needle Localization? - October 22, 2020
- उषा ने एंटी-बैक्टीरियल स्टरलाइजेशन सिस्टम वाली वाटर हीटर रेन्ज लॉन्च की - October 22, 2020
- Czechs enter 2nd lockdown to avoid health system collapse - October 22, 2020
- The new abnormal: vulnerable patients hit by pharmacy closures - October 22, 2020